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which revealed small peripheral pulmonary emboli bilaterally and
treatment with rivaroxaban (Xarelto) was initiated.
After completing threeweeks of treatmentwith rivaroxaban, the pa-
tient experienced her ﬁrst episode of postmenopausal bleeding. A pelvic
ultrasound revealed a 10.4 × 6.0 × 6.4 cm uterus, with endometrial
thickeningmeasuring 3.2 cm and a complex endometrial mass measur-
ing 1.0 × 2.1 × 1.7 cm. In addition, contiguous with the fundus of the
uterus was a complex mass measuring 11.0 × 11.0 × 12.3 cm. The ova-
ries were not visualized bilaterally. Computed Tomography (CT) of the
abdomen and pelvis conﬁrmed the sonographic ﬁndings. An endome-
trial biopsy was attempted, however, ﬁnal pathology revealed insufﬁ-to a tertiary medical center for a gynecologic oncology consultation.1. Introduction
Nonbacterial thrombotic endocarditis (NBTE) is often discovered at
the time of autopsy or in late-stage malignancies, limiting the informa-
tion available about the clinical course of patients with this syndrome.
Themost commonmalignancies associatedwith NBTE are lung, pancre-
atic, gastric cancer and adenocarcinomas of an unknown primary site
(el-Shami et al., 2007). In gynecologic malignancies, NBTE is most com-
monly reported in ovarian cancer (Delgado and Smith, 1975). Our case
is unique not only because the patient survived an event of NBTE with
synchronous primary ovarian and endometrial cancer but also because
the actual clinical manifestation that prompted a cardiac workup was
not related to the NBTE.
2. Case
A 63-year-old menopausal woman presented with new onset of se-
vere dyspnea on exertion and chest tightness. The electrocardiogram
(EKG) revealed T-wave inversion and the cardiac troponins were ele-
vated. She was treated for acute coronary syndrome while a 2-
dimensional echocardiogram and cardiac catheterization did not show
structural abnormalities or ischemia. Due to persistent dyspnea, a⁎ Corresponding author.
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Due to the high suspicion of malignancy the patient was transferred
Given the recent history of a pulmonary embolism, a Doppler of the
lower extremities was obtained and deep vein thrombosis was ruled
out. A chest X-ray showed cardiomegaly while the EKG demonstrated
normal sinus rhythm with left axis deviation, left ventricular hypertro-
phy and nonspeciﬁc ST segment abnormalities. A transthoracic echocar-
diogram showed a trileaﬂet aortic valvewith an echodensity suggestive
of prominent vegetations visible on at least two leaﬂets of the aortic
valve (Fig. 1). Moreover, there was mild anterior and posterior mitral
leaﬂet thickening and suspicion of thickening of the tricuspid valve, al-
though not well deﬁned (Fig. 2). A transesophageal echocardiogram
conﬁrmed the presence of aortic and mitral valve vegetations.
The physical examination revealed a grade I/VI systolic heart mur-
mur but no peripheral signs of infectious endocarditis. Serial blood cul-
tureswere collectedwhichwere negative. As the infectiousworkupwas
negative, patient was started on a heparin algorithm for NBTE. Lupus
anticoagulant antibodies, cardiolipin antibodies, Beta 2 glycoprotein an-
tibodies, protein S, protein C, antithrombin III and Factor V Leiden levels
were all normal. In the presence of a pelvic mass, elevated carbohydrate
antigen (CA) 125 and carcinoembryogenic antigen and a normal colo-
noscopy, it was concluded that the patient's cardiac vegetations were
most likely related to an undiagnosed gynecologic malignancy and the
decision was made to proceed to an exploratory laparotomy.
Due to increased risk of systemic emboli, a retrievable inferior vena
cava (IVC) ﬁlter was placed preoperatively. The patient underwent ex-
ploratory laparotomy that revealed a large left ovarianmasswith frozen
section consistent with an invasive malignancy. Surgical staging and-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Transthoracic echocardiography (TTE) showing focal thickening on the right
coronary cusp and non-coronary cusp of the aortic valve (arrow).
Fig. 3.Transesophageal echocardiogram (TTE) post debulking and chemotherapy showing
resolution of previous aortic valve vegetations.
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patient was transitioned from the heparin algorithm to a weight-
based regimen with enoxaparin. Final pathology revealed a left ovarian
high grade papillary serous adenocarcinoma extending into the pelvic
sidewall with positive pelvic washings, the right ovary had clusters of
atypical cells consistent with a serous adenocarcinoma as well and the
uterus revealed a focus of well differentiated endometrioid adenocarci-
noma of the endometrium. Consensus decision of the tumor board re-
garding the diagnosis of the patient was stage IIC ovarian serous
adenocarcinoma with synchronous stage IA endometrial adenocarcino-
ma (based on the International Federation of Obstetricians andGynecol-
ogists staging system).
The patient completed six cycles of dense dose paclitaxel and
carboplatin with a good response. Prior to the fourth cycle of chemo-
therapy, a repeat transthoracic echocardiogramdemonstrated complete
resolution of aortic and mitral valve vegetations (Fig. 3). Six months
after completion of full dose anticoagulation treatment with
enoxaparin, a repeat CTA of chest showed resolution of prior pulmonary
emboli lesions. The IVC ﬁlter was removed and the patient was
transitioned to prophylactic enoxaparin for an additional six months.
At two- year follow-up, her CA125 has normalized, there is no radio-
graphic evidence of disease recurrence and she has not had any further
thromboembolic events.3. Discussion
In the 1860s Dr. Armand Trousseau described amalignancy-induced
hypercoagulable state predisposing patients with cancer toFig. 2. Transthoracic echocardiography (TTE) showing anterior and posteriormitral leaﬂet
thickening (arrow).thromboembolic phenomena, eponymously named Trousseau's syn-
drome. Nonbacterial thrombotic endocarditis, formerly known as
marantic endocarditis stemming from the Greek word μαραντικός
(marantikos) which means “wasting away,” is a subset of Trousseau's
syndrome and manifests most frequently in autoimmune hypercoagu-
lable states and secondarily in malignancy (el-Shami et al., 2007).
Malignancy-induced NBTE is characterized by sterile small vegeta-
tions composed of ﬁbrin and platelet aggregates that lack bacteria and
inﬂammation. The platelet/ﬁbrin aggregates often adhere to undam-
aged valves with a propensity for the left heart valves, mitral more
than aortic. The exact pathogenesis is not entirely elucidated, but it is
thought that macrophages and monocytes release immunologic factors
that damage the endothelium leading to thrombus formation. The lack
of cellular organization makes the vegetations quite friable and easily
embolizable (Delgado and Smith, 1975; Aryana et al., 2006).
The deﬁnitive diagnosis of NBTE is made by obtaining a pathologic
specimen surgically or upon autopsy. However, procurement of a cardi-
ac specimen is often unrealistic. Therefore, the diagnosis is usuallymade
based on clinical and echocardiographic evidence, in the absence of in-
fectious ﬁndings. New signiﬁcant murmurs and valvular destruction in
NBTE are uncommon, which can distinguish it from infectious endocar-
ditis. Symptoms of systemic or pulmonary embolization appear to be
the most common complication that lead to a search and diagnosis of
NBTE. When there is a high index of suspicion, transthoracic followed
by transesophageal echocardiography should be performed to assess
for vegetations (el-Shami et al., 2007; Aryana et al., 2006).
NBTE associated with gynecologic malignancy has been described
infrequently and inmost of the cases the diagnosis wasmade postmor-
tem (Delgado and Smith, 1975). Three previously published cases have
shown an association between NBTE and ovarian clear cell carcinoma
(Aryana et al., 2006; Devulapalli et al., 2012). Two patients were diag-
nosed with NBTE after a systemic embolization to multiple organs and
one following a cerebrovascular accident. In the latter case, the patient
was treatedwith enoxaparin while workup revealed progression of dis-
ease. An unusual presentation combining NBTE, paraneoplastic cerebel-
lar degeneration and systemic emboli was reported that lead to the
diagnosis of ovarian adenocarcinoma (Singh et al., 2007). The patient
was treated with heparin and passed away three weeks later. A case
of infectious endocarditis superimposed on NBTE with synchronous
endometrioid ovarian and endometrial adenocarcinoma was described
in 2006 (Numnum et al., 2006). In that case, despite resolution of
NBTE onwarfarin, the patient's prognosiswas very poor due tometasta-
tic disease. Another recently published case report with synchronous
ovarian and endometrial cancer describes a patient with massive pul-
monary embolism who subsequently experienced neurological mani-
festations prompting workup that revealed acute ischemic cerebral
lesions and NBTE (Erturk et al., 2015). Finally, isolated cases of ovarian
74 T. Orfanelli et al. / Gynecologic Oncology Reports 17 (2016) 72–74cancer complicated by NBTE with disseminated intravascular coagula-
tion have also been described in literature (Tanaka et al., 2009).
Our patient's clinical presentation is unique as her initial pulmonary
embolism was not a complication of NBTE, indeed her echocardiogram
at that time was normal. Notably, our patient's NBTE was diagnosed al-
most a month after the episode of the pulmonary embolism despite
being on anticoagulation treatment. It was not until vaginal bleeding
raised the suspicion of an underlying malignancy that lead to a more
comprehensive workup with a subsequent echocardiogram revealing
the NBTE.
Despite the poor prognosis of NBTE, our patient improved dramati-
cally due to the aggressive and prompt treatment with immediate initi-
ation of systemic anticoagulation, optimal surgical debulking and
systemic chemotherapy. While the optimal anticoagulation has not
yet been determined, current recommendations of systemic
anticoagulation with low molecular weight heparin or unfractionated
heparin have proven most effective (Whitlock et al., 2012). Although
no trial has compared heparin versuswarfarin, reports indicate a higher
recurrence of thromboembolic events on warfarin in cancer patients
(Lee et al., 2003).
Finally, screening guidelines for patients with unprovoked venous
thromboembolisms are not entirely clear. A recent study showed that
screening with full body CT scan imaging for occult cancer in unpro-
voked thromboembolisms did not provide clinically signiﬁcant beneﬁt.
However, the study included men and women over the age of
18 years (Carrier et al., 2015). It would be interesting to see the clinical
beneﬁt of imagingwith less invasivemodalities, such as ultrasound, in a
population similar to our patient i.e. female and above the age of 40.
4. Conclusion
In the female population, a thromboembolic event may precede the
diagnosis of an occult gynecologicmalignancy or indicate progression of
disease. The diagnosis and treatment of NBTE remains a clinical chal-
lenge. Gynecologic oncologists should have a high index of suspicion
for malignancy-induced NBTE as they will be the ones primarily taking
care of these patients. Furthermore, althoughNBTE portends a very poor
prognosis, we believe that it is important for gynecologic oncologists to
be aware of cases in which patients improved after an NBTE diagnosis
and treatment. To date, themost effective treatment for malignancy-in-
ducedNBTE remains lowmolecularweight heparin, althoughmore pro-
spective data on new anticoagulant agents such as indirect and direct
thrombin inhibitors is imperative. Our case demonstrates that prompt
diagnosis and treatment of NBTE with anticoagulation and treatment
of the underlying malignancy is essential to prevent debilitating, if not
deadly, sequelae.Conﬂict of interest statement
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